Cargando…

Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells

BACKGROUND: Peptide-drug-conjugates (PDCs) are being developed as an effective strategy to specifically deliver cytotoxic drugs to cancer cells. However one of the challenges to their successful application is the relatively low stability of peptides in the blood, liver and kidneys. Since AuNPs seem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalimuthu, Kalishwaralal, Lubin, Bat-Chen, Bazylevich, Andrii, Gellerman, Gary, Shpilberg, Ofer, Luboshits, Galia, Firer, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877385/ https://www.ncbi.nlm.nih.gov/pubmed/29602308 http://dx.doi.org/10.1186/s12951-018-0362-1

Ejemplares similares

Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
por: Furman, Olga, et al.
Publicado: (2022)

Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma
por: Redko, Boris, et al.
Publicado: (2016)

Theranostic system for ratiometric fluorescence monitoring of peptide-guided targeted drug delivery
por: Rozovsky, Alex, et al.
Publicado: (2019)

Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells
por: Gilad, Yosi, et al.
Publicado: (2016)

Targeted drug delivery for cancer therapy: the other side of antibodies
por: Firer, Michael A, et al.
Publicado: (2012)

The Impact of Induction Regimes on Immune Responses in Patients with Multiple Myeloma
por: Firer, Michael A., et al.
Publicado: (2021)

Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
por: Gilad, Yosi, et al.
Publicado: (2021)

Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers
por: Semenova, Olga, et al.
Publicado: (2023)

Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families
por: Yado, S., et al.
Publicado: (2019)

The effect of phospho-peptide on the stability of gold nanoparticles and drug delivery
por: Hou, Zhanwu, et al.
Publicado: (2019)

Synthesis of biogenic gold nano conjugate for increased efficacy and sustained drug release profile of saquinavir
por: Kesarkar, Rohan, et al.
Publicado: (2014)

Research advances in peptide‒drug conjugates
por: Gong, Liming, et al.
Publicado: (2023)

Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice
por: BarathManiKanth, Selvaraj, et al.
Publicado: (2010)

A simple approach for rapid and cost-effective quantification of extracellular vesicles using a fluorescence polarization technique
por: Kalimuthu, Kalishwaralal, et al.
Publicado: (2019)

Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
por: Fang, Yu, et al.
Publicado: (2022)

Peptide Drug Conjugates and Their Role in Cancer Therapy
por: Heh, Ethan, et al.
Publicado: (2023)

Conjugation with gold nanoparticles improves the stability of the KT2 peptide and maintains its anticancer properties
por: Maraming, Pornsuda, et al.
Publicado: (2021)

Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
por: Wu, Mo, et al.
Publicado: (2022)

New Supramolecular Drug Carriers: The Study of Organogel Conjugated Gold Nanoparticles
por: Kowalczuk, Joanna, et al.
Publicado: (2021)

Insights into the Structure and Function of TRIP-1, a Newly Identified Member in Calcified Tissues
por: Arivalagan, Jaison, et al.
Publicado: (2023)

Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer
por: Shahbazi, Reza, et al.
Publicado: (2023)

NGR-peptide−drug conjugates with dual targeting properties
por: Enyedi, Kata Nóra, et al.
Publicado: (2017)

Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
por: Hoppenz, Paul, et al.
Publicado: (2020)

Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
por: Balamkundu, Seetharamsing, et al.
Publicado: (2023)

Improving the Stability of Maleimide–Thiol Conjugation for Drug Targeting
por: Lahnsteiner, Marianne, et al.
Publicado: (2020)

Conjugating Existing Clinical Drugs With Gold Nanoparticles for Better Treatment of Heart Diseases
por: Zhang, Jingwen, et al.
Publicado: (2018)

Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model
por: Sriram, Muthu Irulappan, et al.
Publicado: (2010)

High-Throughput, Multispecies, Parallelized Plasma Stability Assay for the Determination and Characterization of Antibody–Drug Conjugate Aggregation and Drug Release
por: Durbin, Kenneth R., et al.
Publicado: (2017)

On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
por: Vrettos, Eirinaios I, et al.
Publicado: (2018)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma
por: Mateos, María-Victoria, et al.
Publicado: (2020)

ConjuPepDB: a database of peptide–drug conjugates
por: Balogh, Balázs, et al.
Publicado: (2020)

Peptide-Drug Conjugates: A New Hope for Cancer Management
por: Chavda, Vivek P., et al.
Publicado: (2022)

Molecular Dynamics Simulations of Drug-Conjugated Cell-Penetrating Peptides
por: Ivánczi, Márton, et al.
Publicado: (2023)

Facile Synthesis of Peptide-Conjugated Gold Nanoclusters with Different Lengths
por: Ma, Qun, et al.
Publicado: (2021)

Mechanism of Bactericidal Activity of Silver Nitrate – a Concentration Dependent Bi-Functional Molecule
por: Kumar Pandian, Sureshbabu Ram, et al.
Publicado: (2010)

Transporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrier
por: Zhang, Yanhua, et al.
Publicado: (2016)

Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells
por: Sheikpranbabu, Sardarpasha, et al.
Publicado: (2009)

Antibody–Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome–Disruptive Peptide
por: Knewtson, Kelsey E., et al.
Publicado: (2019)

Insights into the Membranolytic Activity of Antimalarial Drug-Cell Penetrating Peptide Conjugates
por: Aguiar, Luísa, et al.
Publicado: (2020)

Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy
por: Lindberg, Jakob, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k4o5bkj2rkc9u7nfktc56pmjrh